166 related articles for article (PubMed ID: 29784273)
1. Halogenated trimethoprim derivatives as multidrug-resistant Staphylococcus aureus therapeutics.
Nilchan N; Phetsang W; Nowwarat T; Chaturongakul S; Jiarpinitnun C
Bioorg Med Chem; 2018 Oct; 26(19):5343-5348. PubMed ID: 29784273
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
3. [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
Bismuth R; Jarlier V; Grosset J
Pathol Biol (Paris); 1983 May; 31(5):429-33. PubMed ID: 6353335
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
Elwell LP; Wilson HR; Knick VB; Keith BR
Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, antibacterial activity and docking study of some new trimethoprim derivatives.
Rashid U; Ahmad W; Hassan SF; Qureshi NA; Niaz B; Muhammad B; Imdad S; Sajid M
Bioorg Med Chem Lett; 2016 Dec; 26(23):5749-5753. PubMed ID: 28327306
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity on Staphylococcus aureus of original trimethoprim analogues tested alone or in association with sulfamethoxazole.
Kassis J; Simeon De Buochberg M; Giral L; Calas M; Maillols H; Despaux E; Attisso MA
J Chemother; 1989 Jul; 1(4 Suppl):214-7. PubMed ID: 16312375
[No Abstract] [Full Text] [Related]
7. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
[TBL] [Abstract][Full Text] [Related]
8. Frequent occurrence of trimethoprim-sulfamethoxazole hetero-resistant Staphylococcus aureus isolates in different African countries.
Coelho C; de Lencastre H; Aires-de-Sousa M
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1243-1252. PubMed ID: 28160148
[TBL] [Abstract][Full Text] [Related]
9. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of three newly-synthesized chalcones & synergism with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
Božić DD; Milenković M; Ivković B; Ćirković I
Indian J Med Res; 2014 Jul; 140(1):130-7. PubMed ID: 25222788
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus.
Chan EWL; Yee ZY; Raja I; Yap JKY
J Glob Antimicrob Resist; 2017 Sep; 10():70-74. PubMed ID: 28673701
[TBL] [Abstract][Full Text] [Related]
13. Influence of ionizing radiation on the antimicrobial activity of the antibiotics sulfamethoxazole and trimethoprim.
Sági G; Szabacsi K; Szabó L; Homlok R; Kovács K; Mohácsi-Farkas C; Pillai SD; Takács E; Wojnárovits L
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2018 Jul; 53(8):687-693. PubMed ID: 29485359
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA).
Gatadi S; Gour J; Kaul G; Shukla M; Dasgupta A; Akunuri R; Tripathi R; Madhavi YV; Chopra S; Nanduri S
Bioorg Chem; 2018 Dec; 81():175-183. PubMed ID: 30130650
[TBL] [Abstract][Full Text] [Related]
15. Charged Propargyl-Linked Antifolates Reveal Mechanisms of Antifolate Resistance and Inhibit Trimethoprim-Resistant MRSA Strains Possessing Clinically Relevant Mutations.
Reeve SM; Scocchera E; Ferreira JJ; G-Dayanandan N; Keshipeddy S; Wright DL; Anderson AC
J Med Chem; 2016 Jul; 59(13):6493-500. PubMed ID: 27308944
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activity of novel icariin derivatives.
Wang A; Xu Y
Pharmazie; 2019 Feb; 74(2):73-78. PubMed ID: 30782254
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial evaluation of 13-substituted cycloberberine derivatives as a novel class of anti-MRSA agents.
Fan TY; Wang YX; Tang S; Hu XX; Zen QX; Pang J; Yang YS; You XF; Song DQ
Eur J Med Chem; 2018 Sep; 157():877-886. PubMed ID: 30145374
[TBL] [Abstract][Full Text] [Related]
18. Toward Broad Spectrum Dihydrofolate Reductase Inhibitors Targeting Trimethoprim Resistant Enzymes Identified in Clinical Isolates of Methicillin Resistant
Reeve SM; Si D; Krucinska J; Yan Y; Viswanathan K; Wang S; Holt GT; Frenkel MS; Ojewole AA; Estrada A; Agabiti SS; Alverson JB; Gibson ND; Priestley ND; Wiemer AJ; Donald BR; Wright DL
ACS Infect Dis; 2019 Nov; 5(11):1896-1906. PubMed ID: 31565920
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
Grim SA; Rapp RP; Martin CA; Evans ME
Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Antibacterial Activity Against MRSA of Pleuromutilin Derivatives Possessing a Mercaptoethylamine Linker.
Zhang ZS; Huang YZ; Luo J; Wang BF; Jin Z; Liu YH; Tang YZ
Med Chem; 2018; 14(6):585-594. PubMed ID: 29663895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
